The global plant extracts market is projected to grow from $50.91 billion in 2026 to $83.38 billion by 2032, at a CAGR of 8.51%. Growth is fueled by rising demand for clean-label ingredients, preventive health trends, and innovations in botanical formulations. Advances in AI and extraction technologies enhance product quality, consistency, and discovery, opening new opportunities in nutraceuticals, cosmetics, and pharmaceuticals. Regional dynamics and sustainability practices also shape market strategies and competitive advantages.
The plant extracts market forecast to reach USD 83.38 billion by 2032 provides context for basic materials trading on Pluang. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 29, 2026 21:03 WIB: out of 83 priced US stocks, 27 rose and 56 fell. Notably, AUGO traded at USD 79.07 with a 3.36% decline, NG at USD 6.05 down 3.35%, and BTG at USD 4.95 down 3.32% with a 60% sell order activity and a typical hold time of 5 days on Pluang.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
